Skip to content
10-Q

Quarterly Report

LifeMD, Inc. LFMD LFMDP

0001493152-26-021536

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 48.36M sh
Shares Diluted Q1 2026 · Mar 31, 2026 47.34M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 43.14M sh
Capex Q1 2026 · Mar 31, 2026 $105.18K
Capex restated Q1 2026 · Mar 31, 2025 $117.55K
Operating Cash Flow Q1 2026 · Mar 31, 2026 $444.62K
Operating Cash Flow Q1 2026 · Mar 31, 2025 $3.07M
Stockholders Equity Q1 2026 · Mar 31, 2026 $15.04M
Stockholders Equity Q1 2026 · Dec 31, 2025 $23.16M
Current Liabilities Q1 2026 · Mar 31, 2026 $49.59M
Current Liabilities Q1 2026 · Dec 31, 2025 $41.57M
Total Liabilities Q1 2026 · Mar 31, 2026 $55.09M
Total Liabilities Q1 2026 · Dec 31, 2025 $47.25M
Current Assets Q1 2026 · Mar 31, 2026 $51.7M
Current Assets Q1 2026 · Dec 31, 2025 $51.83M
Total Assets Q1 2026 · Mar 31, 2026 $70.12M
Total Assets Q1 2026 · Dec 31, 2025 $70.41M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.20
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.02
Eps Basic Q1 2026 · Mar 31, 2026 −$0.20
Eps Basic Q1 2026 · Mar 31, 2025 −$0.02
Sga Expense Q1 2026 · Mar 31, 2026 $15.18M
Sga Expense restated Q1 2026 · Mar 31, 2025 $14.34M
Net Income Q1 2026 · Mar 31, 2026 −$8.87M
Net Income restated Q1 2026 · Mar 31, 2025 −$183.78K
Operating Income Q1 2026 · Mar 31, 2026 −$8.93M
Operating Income restated Q1 2026 · Mar 31, 2025 −$1.18M
Gross Profit Q1 2026 · Mar 31, 2026 $44.24M
Gross Profit restated Q1 2026 · Mar 31, 2025 $42.75M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $5.93M
Cost Of Revenue restated Q1 2026 · Mar 31, 2025 $8.14M
Revenue Q1 2026 · Mar 31, 2026 $50.16M
Revenue restated Q1 2026 · Mar 31, 2025 $50.89M